Five-year Maintenance Results of an Obesity Drug Following a Very Low Calorie Diet (VLCD) Presented at Obesity Week, 2013

by Cassidy Older | Mar 12, 2013 | Research

J Loper, R Lutes, T Broyles, R May, E Baltes.

Naltrexone SR/Bupropion SR Combination Therapy Reduces Total and Visceral Adiposity in Overweight and Obese Subjects in the COR-1 Study. American Diabetes Association, 2011.

by Cassidy Older | Mar 12, 2011 | Research

Smith S, T Church, J Goohas, C Griffin, W Harper, D Krieger, J Loper, Smudahar, C Woodrugg, M Guittalauria, E Henry, D Kim, E Dunayevich.

Naltrexone SR/Bupropion SR Therapy Reduced Body Weight and HgbA1C in Overweight/Obese Women with Type 2 Diabetes. American Diabetes Association, 2011.

by Cassidy Older | Mar 12, 2011 | Research

P Hollander, J Loper, L Mignon, C Burns, R Harris-Collzao, D Kim.

Drug Treatment following a VLCD (Very Low Energy Diet). Obesity, Research Journal, 2010

by Cassidy Older | Mar 12, 2010 | Research

Loper J, RA Lutes, JT Broyles, EJ Baltes, RK May.

Completed Research: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Safety and Efficacy of Two Doses of Naltrexone Sustained Release, SR/Buproprion and Placebo in Obese Subjects. 2007-2009.

by Cassidy Older | Mar 26, 2009 | Uncategorized